HYDERGINE TABLETS, 1MG 1 MG
ERGOLOID MESYLATES : 1 MG · DIN 00176176 · STERIMAX INC
Health Canada status: DORMANT
What is HYDERGINE TABLETS, 1MG?
HYDERGINE TABLETS, 1MG 1 MG contains ERGOLOID MESYLATES : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 00176176, held by STERIMAX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 24-Jul-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00176176 |
|---|---|
| Brand name | HYDERGINE TABLETS, 1MG |
| Generic / active ingredient | ERGOLOID MESYLATES : 1 MG |
| Manufacturer | STERIMAX INC |
| Strength | 1 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C04AE01 ERGOLOID MESYLATES |
| AHFS class | 28:24.04 ; 12:16.00 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 24-Jul-2020 |
| Original market date | 1958-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 00176176 |
|---|---|
| DIN (unpadded, as printed on some documents) | 176176 |
| Brand name | HYDERGINE TABLETS, 1MG |
| Active ingredient / INN | ERGOLOID MESYLATES : 1 MG |
| ATC code | C04AE01 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C04 |
| AHFS class | 28:24.04 ; 12:16.00 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | STERIMAX INC |
Which pack is which?
| Strength on the label | 1 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.